Skip to main content
Colorado General AssemblyToggle Main Menu
Agency NameToggle Agency Menu

9885BADE896D045887258831006B3811 Hearing Summary




PUBLIC
BILL SUMMARY For HB22-1344

SENATE COMMITTEE ON HEALTH & HUMAN SERVICES
Date Apr 27, 2022      
Location SCR 357



HB22-1344 - Referred to the Committee of the Whole - Consent Calendar


01:31:11 PM  
Senator Cook and
Senator Ginal, co-prime bill sponsors, presented House Bill 22-1344, which
specifies that prescription drugs containing 3,4-methylenedioxymethamphetmine,
approved by the federal Food and Drug Administration, and placed on a schedule
other than schedule I are legal to prescribe, dispense, transport, possess,
and use in Colorado.



Committee members asked questions of the bill sponsors.

01:39:58 PM  
Dr. Will Van, representing self, testified in support of the bill.

Mr. Kyle Kinney, representing self, testified in support of the bill.

01:45:27 PM  
Dr. Scott Shannon,
representing self, testified in support of the bill.



Mr. Jonathan Lubecky, representing self, testified in support of the bill.



Committee members made comments to the panel.

01:53:24 PM  
Bill sponsors provided closing remarks.
01:54:01 PM  
Committee members provided closing remarks.


01:55:57 PM
Motion Refer House Bill 22-1344 to the Committee of the Whole and with a recommendation that it be placed on the consent calendar.
Moved Ginal
Seconded
Buckner Yes
Jaquez Lewis Excused
Kirkmeyer Yes
Simpson Yes
Smallwood Excused
Ginal Yes
Fields Yes
Final YES: 5   NO: 0   EXC: 2   ABS:  0   FINAL ACTION:  PASS






The effective date for bills enacted without a safety clause is August 6, 2025, if the General Assembly adjourns sine die on May 7, 2025 (unless otherwise specified). Details

Request for Proposal for the COL study. Details

Our website is currently undergoing a redesign in order to provide a better experience for everyone. View the Beta site

Request for Proposals for Colorimetric Working Group. Click Here